Home
Conditions
Lymphoma, T-Cell

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

NCT00962507

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +49 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope Medical Group Pasadena, California, United States

View Trial Details

Completed

Gemcitabine in NK/T Cell Lymphoma

NCT01660568

Conditions: Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

NCT00002625

Conditions: Bronchial Neoplasms, Burkitt Lymphoma, Carcinoma, Bronchogenic, +52 more
Locations: University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States

View Trial Details

Completed

BMS-247550 in Treating Patients With Advanced Cancers

NCT00006221

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Cancer Therapy and Research Center San Antonio, Texas, United States

Veterans Affairs Medical Center - San Antonio (Murphy) San Antonio, Texas, United States

University of Texas Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Penclomedine in Treating Patients With Solid Tumors or Lymphoma

NCT00002946

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States

View Trial Details

Completed

Perillyl Alcohol in Treating Patients With Refractory Cancer

NCT00002862

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Yale Comprehensive Cancer Center New Haven, Connecticut, United States

View Trial Details

Completed

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

NCT00004189

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: University of Texas Health Science Center at San Antonio San Antonio, Texas, United States

Cancer Therapy and Research Center San Antonio, Texas, United States

St. Luke's Lutheran Hospital San Antonio, Texas, United States

View Trial Details

Completed

Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00278382

Conditions: Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma

NCT00004241

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +105 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

NCT00025415

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, +170 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Lymphoma, T-Cell

Lymphoma, T-Cell trial results

Related conditions